Related references
Note: Only part of the references are listed.The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting
Martine J. Smit et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
Yolla Haibe et al.
FRONTIERS IN ONCOLOGY (2020)
Translating IL-6 biology into effective treatments
Ernest H. Choy et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
COX5B-Mediated Bioenergetic Alteration Regulates Tumor Growth and Migration by Modulating AMPK-UHMK1-ERK Cascade in Hepatoma
Yu-De Chu et al.
CANCERS (2020)
PARP inhibitor resistance: the underlying mechanisms and clinical implications
He Li et al.
MOLECULAR CANCER (2020)
Biomarkers and Strategies for Early Detection of Ovarian Cancer
Robert C. Bast et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Noncanonical IL6 Signaling-Mediated Activation of YAP Regulates Cell Migration and Invasion in Ovarian Clear Cell Cancer
Walid J. Azar et al.
CANCER RESEARCH (2020)
Inhibition of VEGFA Increases the Sensitivity of Ovarian Cancer Cells to Chemotherapy by Suppressing VEGFA-Mediated Autophagy
Xia Li et al.
ONCOTARGETS AND THERAPY (2020)
FYN is required for ARHGEF16 to promote proliferation and migration in colon cancer cells
Bei Yu et al.
CELL DEATH & DISEASE (2020)
Most Commonly Mutated Genes in High-Grade Serous Ovarian Carcinoma Are Nonessential for Ovarian Surface Epithelial Stem Cell Transformation
Robert Joseph Yamulla et al.
CELL REPORTS (2020)
The Role of CCL20-CCR6 Axis in Ovarian Cancer Metastasis
Wan Liu et al.
ONCOTARGETS AND THERAPY (2020)
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer
Qing Wang et al.
THERANOSTICS (2020)
Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence
Qiao Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts
Rangasudhagar Radhakrishnan et al.
CANCER LETTERS (2019)
Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium
Jun Guan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
The Role of ACKR3 in Breast, Lung, and Brain Cancer
Maria Neves et al.
MOLECULAR PHARMACOLOGY (2019)
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
Minna Sopo et al.
BMC CANCER (2019)
Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells
Lihua Chen et al.
CELLULAR ONCOLOGY (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
CCL20 Promotes Ovarian Cancer Chemotherapy Resistance by Regulating ABCB1 Expression
Shan Su et al.
CELL STRUCTURE AND FUNCTION (2019)
A Convergence-Based Framework for Cancer Drug Resistance
David J. Konieczkowski et al.
CANCER CELL (2018)
LPA Induces Metabolic Reprogrammingin Ovarian Cancer via a Pseudohypoxic Response
Ji Hee Ha et al.
CANCER RESEARCH (2018)
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Thomas M. Ashton et al.
CLINICAL CANCER RESEARCH (2018)
FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node
Ga-Hang Lee et al.
ONCOGENE (2018)
PARP Inhibitors in Ovarian Cancer
Gloria Mittica et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2018)
Identification of Hub Genes and Key Pathways Associated with Two Subtypes of Diffuse Large B-Cell Lymphoma Based on Gene Expression Profiling via Integrated Bioinformatics
Zijian Liu et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Anti-Angiogenics: Current Situation and Future Perspectives
Katja Zirlik et al.
ONCOLOGY RESEARCH AND TREATMENT (2018)
Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
Amruta P. Nayak et al.
CANCERS (2018)
IL-6 mediates platinum -induced enrichment of ovarian cancer stem cells
Yinu Wang et al.
JCI INSIGHT (2018)
High expression of COX5B is associated with poor prognosis in breast cancer
Shui-Ping Gao et al.
FUTURE ONCOLOGY (2017)
Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research
Jennifer A. Doherty et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research
Jennifer A. Doherty et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Anti-angiogenic agents in ovarian cancer: past, present, and future
B. J. Monk et al.
ANNALS OF ONCOLOGY (2016)
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium
Nicolas Wentzensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gai2, Src, and HIF1α signaling nexus
Ji Hee Ha et al.
ONCOTARGET (2016)
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
Tsz-Lun Yeung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
LPA-mediated migration of ovarian cancer cells involves translocalization of Gαi2 to invadopodia and association with Src and β-pix
Jeremy D. Ward et al.
CANCER LETTERS (2015)
cytoHubba: identifying hub objects and sub-networks from complex interactome
Chia-Hao Chin et al.
BMC SYSTEMS BIOLOGY (2014)
Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
Sunila Pradeep et al.
CANCER CELL (2014)
Suppression of GNAI2 message in ovarian cancer
John R. Raymond et al.
JOURNAL OF OVARIAN RESEARCH (2014)
Targeting Signaling Pathways in Epithelial Ovarian Cancer
Elisabeth Smolle et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Cyclin I correlates with VEGFR-2 and cell proliferation in human epithelial ovarian cancer
Marek Cybulski et al.
GYNECOLOGIC ONCOLOGY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Amplification of the UQCRFS1 Gene in Gastric Cancers
Kyong Hwa Jun et al.
JOURNAL OF GASTRIC CANCER (2012)
Oxidative phosphorylation in cancer cells
Giancarlo Solaini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)
The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis
Maik Huettemann et al.
MITOCHONDRION (2011)
Impaired OXPHOS Complex III in Breast Cancer
Kjerstin M. Owens et al.
PLOS ONE (2011)
Targeted Therapy in Ovarian Cancer
Lyndsay J. Willmott et al.
JOURNAL OF ONCOLOGY (2010)
DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2007)
Ubiquinol cytochrome c reductase (UQCR-FS1) gene amplification in primary breast cancer core biopsy samples
Y Ohashi et al.
GYNECOLOGIC ONCOLOGY (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
VIP as a trophic factor in the CNS and cancer cells
TW Moody et al.
PEPTIDES (2003)
Initiating oncogenic event determines gene-expression patterns of human breast cancer models
KV Desai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
